StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.83−0.32 (-15.08%)

Close on Nov 18, 2026Market cap $8.18MP/E –Yield –

Bluejay Diagnostics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bluejay Diagnostics's revenue for the twelve months ending Dec 31, 2022 was $249.04K. For fiscal 2022 it was $249.04K.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$249.04K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$249.04K–

More Bluejay Diagnostics figures

See a number that looks wrong?